Hagit Cohen | Medicine and Health Sciences | Research Excellence Award

Published on by Research Hypothesis

Prof. Hagit Cohen | Medicine and Health Sciences | Research Excellence Award

Prof. Hagit Cohen | Medicine and Health Sciences | Head of Anxiety at Ben Gurion University | Israel

Prof. Hagit Cohen is a distinguished neuroscientist and psychiatrist internationally recognized for her pioneering contributions to stress biology, psychobiology, and translational research in anxiety and post-traumatic stress disorder. Prof. Hagit Cohen completed her undergraduate training in life sciences and her master’s and doctoral education in biomedical engineering and life sciences at Ben-Gurion University of the Negev, where her doctoral research focused on neurophysiological and spectral analysis approaches to mental fatigue and stress-related mechanisms. She later advanced her expertise through postdoctoral training in clinical biochemistry and pharmacology, strengthening her translational orientation between basic neuroscience and clinical psychiatry. Prof. Hagit Cohen currently serves as a senior academic leader in psychiatry and neuroscience, holding prestigious chaired and professorial positions while directing a nationally influential Anxiety and Stress Research Unit that integrates clinical, behavioral, neuroendocrine, and molecular approaches. Prof. Hagit Cohen is highly skilled in translational animal models, psychopharmacology, neuroendocrine profiling, behavioral neuroscience, biomarker discovery, and interdisciplinary clinical research design. She has authored 212 documents, received 13,692 citations, and holds an h-index of 65, reflecting the sustained international impact of her scholarship.

Citation Metrics (Scopus)

25000

20000

15000

10000

5000

0

Citations
13,692

Documents
212

h-index
65

🟦 Citations       🟥 Documents    🟩 h-index


View Scopus Profile
       View ORCID Profile     View Google Scholar Profile

Featured Publications

Exploring the Anxiolytic Potential of NPY by a Dipeptidyl Peptidase-IV Inhibitor in an Animal Model of PTSD
– International Journal of Neuropsychopharmacology, 2024 (7 Citations)
Loss of the Zinc Receptor ZnR/GPR39 in Mice Enhances Anxiety-Related Behavior and Motor Deficits, and Modulates KCC2 Expression in the Amygdala
– Behavioral and Brain Functions, 2024 (1 Citation)
ZNF142 Mutation Causes Sex-Dependent Neurologic Disorder
– Journal of Medical Genetics, 2024 (4 Citations)
Neuro-Psychiatric Symptoms in Directly and Indirectly Blast-Exposed Civilian Survivors of Urban Missile Attacks
– BMC Psychiatry, 2023 (6 Citations)
Sounds of Danger and Post-Traumatic Stress Responses in Wild Rodents: Ecological Validity of a Translational Model of PTSD
– Molecular Psychiatry, 2023 (6 Citations)
Hydrocortisone in the Emergency Department: A Prospective, Double-Blind, Randomized Controlled PTSD Study
– CNS Spectrums, 2023 (8 Citations)
Promoter Methylation of the Glucocorticoid Receptor Following Trauma and Its Association With PTSD Development
– World Journal of Biological Psychiatry, 2023 (5 Citations)

Laurie Margolies | Medicine and Health Sciences | Excellence in Research Award

Published on by Research Hypothesis

Dr. Laurie Margolies | Medicine and Health Sciences | Excellence in Research Award

Dr. Laurie Margolies | Medicine and Health Sciences | Excellence in Research Award | MD | Icahn School of Medicine at Mount Sinai | United States

Dr. Laurie Margolies is a distinguished radiologist and internationally respected leader in breast imaging, currently serving as Professor and Vice Chair for Breast Imaging in the Department of Diagnostic, Molecular, and Interventional Radiology at the Icahn School of Medicine at Mount Sinai, where she has made transformative contributions to breast cancer detection, digital imaging, and women’s health. Dr. Laurie Margolies completed her undergraduate studies in Biomedical Ethics at Brown University, earned her medical degree from Yale University School of Medicine, and pursued advanced clinical training through an internal medicine internship at Griffin Hospital, a radiology residency at Columbia-Presbyterian Medical Center, and a comprehensive fellowship in CT, ultrasound, and MRI at Yale University/Yale New Haven Hospital. Her professional experience spans decades of academic appointments, including Instructor at Yale, rising through faculty ranks at Mount Sinai from Assistant Professor to full Professor, while simultaneously serving as System Chief of Breast Imaging across multiple hospitals, Director of Breast Imaging at Mount Sinai Hospital, and Chief of Breast Imaging at the Dubin Breast Center. Dr. Laurie Margolies’s research interests center on breast cancer screening optimization, digital mammography, cardiovascular risk evaluation through mammographic arterial calcifications, health disparity reduction, culturally targeted education programs, imaging physics, AI-driven diagnostic tools, and cross-disciplinary cancer detection methods. Her research skills include expertise in multimodality breast imaging, tomosynthesis assessment, radiologic quality control, population-based screening program development, clinical guideline evaluation, and participation in collaborative research teams across oncology, epidemiology, psychology, and medical physics. She has contributed to impactful studies published in reputable journals such as the Journal of Breast Imaging, Clinical Imaging, Journal of Cancer Education, and PEC Innovation, and she has served on multiple advisory boards for leading medical technology companies, advancing AI-assisted imaging development. Dr. Laurie Margolies has received numerous honors, including Fellowship in the American College of Radiology, Fellowship in the Society of Breast Imaging, multiple RSNA Merit Awards, Mount Sinai Innovation Awards, Clinical Imaging Outstanding Reviewer recognition, and repeated selection as a Castle Connolly Top Doctor. She has served on key institutional committees, leadership panels, and mentoring programs, significantly shaping radiologic quality improvement and cancer screening strategies. Dr. Laurie Margolies continues to influence clinical practice through her dedication to research, patient-centered care, and educational advancement, embodying excellence in academic radiology and demonstrating ongoing potential to elevate global breast imaging standards.

Profile: ORCID | Google Scholar

Featured Publications 

  1. Margolies, L. R., Spear, G. G., Payne, J. I., Iles, S. E., & Abdolell, M. (2025). Artificial intelligence for assessment of digital mammography positioning reveals persistent challenges.

  2. Rossi, J., Cho, L., Newell, M. S., Venta, L. A., Montgomery, G. H., Destounis, S. V., Brem, R. F., Parghi, C., & Margolies, L. R. (2025). Breast arterial calcifications on mammography: A review of the literature.

  3. Mullen, L. A., Ambinder, E. B., Talati, N., & Margolies, L. R. (2023). Mammography information systems: A survey of breast imaging radiologist satisfaction and perspectives.

  4. Head, K. J., Harrington, N. G., Schnur, J. B., Margolies, L., & Montgomery, G. H. (2022). Examining gain- and loss-framed messages in a novel breast cancer screening/cardiovascular context: Does framing matter.

  5. Vang, S., Margolies, L. R., & Jandorf, L. (2022). Screening mammogram adherence in medically underserved women: Does language preference matter.

  6. Fung, J., Vang, S., Margolies, L. R., Li, A., Blondeau-Lecomte, E., Li, A., & Jandorf, L. (2021). Developing a culturally and linguistically targeted breast cancer educational program for a multicultural population.

  7. Margolies, L. R., Salvatore, M., Yip, R., Tam, K., Bertolini, A., Henschke, C., & Yankelevitz, D. (2018). The chest radiologist’s role in invasive breast cancer detection.

 

Katarzyna Madziarska | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Assoc. Prof. Dr. Katarzyna Madziarska | Medicine and Health Sciences | Best Researcher Award

Medicine and Health Sciences | Head of Department | Wroclaw Medical University | Poland

Assoc. Prof. Dr. Katarzyna Madziarska is a distinguished Polish clinician-scientist, educator, and researcher whose career has been dedicated to advancing the fields of diabetology, nephrology, and internal medicine through outstanding academic leadership, clinical practice, and research excellence. She obtained her MD and PhD from Wroclaw Medical University, where she currently serves as Head of the Clinical Department of Diabetology, Hypertension, and Internal Diseases, a position that allows her to combine patient care with cutting-edge research and medical education. Her professional experience spans decades, including roles as resident, assistant, senior assistant, adjunct, and ultimately associate professor, giving her a comprehensive understanding of clinical and academic medicine. She has been actively involved in postgraduate medical training and serves as a coordinator for trainees, a member of doctoral and habilitation committees, and a lecturer at both undergraduate and postgraduate levels. Her research interests are focused on micro- and macrovascular complications of diabetes, diabetic nephropathy, chronic kidney disease, transplantology, and the long-term health consequences of COVID-19. She has authored 112 documents, 1,076 citations, and 15 h-index, demonstrating her sustained scientific output and influence within the international medical community. Her research skills include designing and coordinating clinical trials (Phase III and IV) as a principal investigator and national coordinator, reviewing manuscripts for international journals, supervising PhD theses, and managing multi-disciplinary research projects like the COLOS study on COVID-19 outcomes. She is also experienced in translational research linking immunological, metabolic, and renal parameters to improve clinical practice. Assoc. Prof. Dr. Katarzyna Madziarska is an active member of prestigious professional bodies such as the Polish Society of Nephrology (President of the Lower Silesia Branch), Polish Society of Diabetology (Board Member), and the Polish Academy of Sciences Clinical Sciences Committee, where she contributes to advancing healthcare policy and scientific development. Her organizational contributions include serving on the Senate and Faculty Council of Medical Sciences at Wroclaw Medical University, membership in the Bioethics Committee, and participation in the Scientific Council for Clinical Trials, demonstrating her commitment to institutional governance and ethical research conduct.

Profile :  Scopus | ORCID

Featured Publications

  1. Diabetes Mellitus and Old Age – Risk Factors in Renal Replacement Therapy – 2020 – Citations: 48

  2. Evaluation of Immunological Parameters in Lipid Metabolism Disturbances in Primary Glomerulonephritis – 2019 – Citations: 35

  3. Microvascular and Macrovascular Complications in Diabetic Nephropathy: Clinical Predictors and Outcomes – 2021 – Citations: 62

  4. Post-COVID-19 Complications and Kidney Function: A Clinical Perspective – 2022 – Citations: 54

  5. Clinical Trials in Diabetes and Chronic Kidney Disease: Lessons from Multicenter Studies – 2023 – Citations: 39

  6. Role of Molecular Mechanisms in Homeostasis Regulation in Nephrology – 2020 – Citations: 42

 

Christina Pettan-Brewer | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Assoc. Prof. Dr . Christina Pettan-Brewer | Medicine and Health Sciences | Best Researcher Award

Assoc. Prof. Dr. Christina Pettan-Brewer | Medicine and Health Sciences | Associate Professor and Director | School of Medicine University of Washington | United States

Associate Professor Dr. Christina Pettan-Brewer is a distinguished veterinary scientist and global health leader whose career bridges research, education, and international policy. With advanced training in veterinary medicine, genetics, epidemiology, and One Health, she has contributed significantly to understanding zoonotic diseases, environmental health, and the genetic and molecular mechanisms of aging and disease. She serves as a key advisor and expert for international organizations including UNEP Nature for Health, WHO, PREZODE, and the International Alliance against Health Risks in Wildlife Trade, demonstrating her influence on global health strategies and pandemic prevention platforms. As Senior Editor of CABI One Health and Editor-in-Chief of Beyond One Ocean Health, she plays a pivotal role in advancing interdisciplinary scientific communication. Multilingual and internationally engaged, she combines her academic role at the University of Washington with mentorship, Fulbright program leadership, and advocacy for underrepresented groups in science, making her a recognized authority in One Health, planetary health, and global public health innovation.

Professional Profile 

Education  

Associate Professor Dr. Christina Pettan-Brewer has a strong and diverse educational background that reflects her interdisciplinary expertise. She began her academic journey in Brazil, earning a technical degree in Zoology and Clinical Pathology, followed by a Doctor of Veterinary Medicine with honors from the Universidade Federal de Viçosa. She then pursued advanced studies in the United States at the University of California, Davis, completing a Master of Science in Wildlife and Zoological Medicine and Comparative Pathology while also receiving accreditation as a Doctor of Veterinary Medicine. To further strengthen her expertise in global health, she obtained a PhD in One Health and Global Health from the Federal University of Paraná in collaboration with the University of Colorado, specializing in Indigenous Health and Emerging Infectious Diseases. Her educational achievements, marked by honors and top performance, form the foundation of her career in veterinary medicine, public health, genetics, and planetary health.

Professional Experience

Associate Professor Dr. Christina Pettan-Brewer has built an impressive professional career that integrates academic leadership, research, and international advisory roles. She began her faculty journey as an Assistant Professor at Centenary University in New Jersey, where she developed curricula for pre-veterinary and pre-medicine programs while conducting research on avian pathology during the West Nile Virus outbreak. At the University of Washington School of Medicine, she has advanced through roles as Acting Instructor, Acting Assistant Professor, and now Associate Professor in the Department of Comparative Medicine, contributing extensively to research in genetics, zoonotic diseases, and One Health. Beyond academia, she has served as a senior advisor and technical expert for global organizations such as UNEP, WHO, PREZODE, and international veterinary associations, shaping global health strategies and pandemic preparedness. Her editorial leadership with CABI One Health and Beyond One Ocean Health further demonstrates her influence in scientific communication, while her Fulbright program advisory role highlights her dedication to mentoring and international academic exchange.

Research Interest

Associate Professor Dr. Christina Pettan-Brewer’s research interests lie at the intersection of veterinary medicine, public health, and planetary health, with a strong emphasis on the One Health approach. She focuses on zoonotic and emerging infectious diseases, pandemic prevention, and the interconnectedness of human, animal, and environmental health. Her work extends to the genetic and molecular mechanisms of aging, chronic diseases, and susceptibility to toxins, as well as the health impacts of climate change and biodiversity loss. She is particularly interested in Indigenous health, global health equity, and the role of wildlife and ecosystem preservation in preventing future pandemics. Through her interdisciplinary research, she seeks to advance collaborative solutions that strengthen global health systems, protect vulnerable populations, and promote sustainable, resilient communities

Award and Honor

Associate Professor Dr. Christina Pettan-Brewer has been recognized with numerous honors and prestigious appointments that highlight her global leadership in One Health and public health. She has served as a United Nations Environment Programme (UNEP) One Health Expert and Technical Advisory Group member for the Nature for Health initiative, representing Latin America and later co-chairing its expert committee. Her expertise has been sought by the World Health Organization’s Global Preparedness Monitoring Board, PREZODE’s International Data Working Group, and the Agence Nationale de la Recherche in France for evaluating pandemic prevention strategies. She has also been appointed as a Fulbright Program Adviser, National Scholar Program Ambassador, and Reviewer, reflecting her commitment to international education and research exchange. In addition, her editorial leadership roles as Senior Editor of CABI One Health and Editor-in-Chief of Beyond One Ocean Health stand as significant honors that demonstrate her influence in shaping global scientific dialogue. These achievements collectively underscore her distinguished reputation as a trusted advisor, scholar, and thought leader in global health.

Publications Top Noted

Effects of Covid-19 Pandemic in the Surveillance and Control of Neglected Tropical Diseases and Malaria: A Systematic Review

Year: 2025

Protecting Urban Wildlife Fauna, Fighting Zoonoses, and Preventing Biophobia in Brazil

Year: 2025

Conclusion

Dr. Christina Pettan-Brewer is a highly suitable candidate for the Best Researcher Award. Her career exemplifies global leadership, interdisciplinary research, and a strong commitment to advancing One Health, pandemic prevention, and planetary health. With a proven record of academic excellence, international collaboration, and impactful advisory roles, she stands out as a researcher whose work bridges science, policy, and education. Addressing minor improvements related to visibility of individual research outputs would further strengthen her profile, but her broad and meaningful contributions make her a compelling and deserving nominee for this recognition.